Are your patients ready to embrace change?

Article

Happy New Year to you all. I'm sure, by now, the memories of Christmas have faded and the New Year's resolutions have already been broken but I do hope you used the holiday season to recharge your batteries, ready to face whatever 2007 may bring.

We kick off this year with a special focus on the ageing eye - presbyopia. As with all surgical procedures, we highlight the importance of patient communication here. Indeed, some specialists believe that effective communication could yield a practice with a near 100% patient satisfaction record. We have tried our best to cover this diverse and complex area of research, but I'm sure that the best is yet to come. As the year unfolds, I imagine we will be seeing the treatment of presbyopia evolve significantly as the pace of research and development looks set to step up a gear.

Going back to the subject of communication, I was talking with my grandmother over the Christmas break about her progress since she had undergone cataract surgery two months earlier. Now, I admit that English is not her first language and my spoken Greek is far from perfect but, with the help of my trusted translator (my Mother), I asked her how she felt following her surgery. She said that she felt fine but didn't understand why her vision was now blurred with her current prescription of spectacles. When I asked her to remove her spectacles and look at the television, I asked her if she could see better. She confirmed that she could but she insisted on keeping her spectacles on as she was afraid of "developing a headache".

I'd like to thank you for joining us at the beginning of what I'm sure will be another great year.

Fedra Pavlou Editorfpavlou@advanstar.com

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.